Genetic heterogeneity in rectal cancer: Identification of subpopulations of tumor cells resistant to neoadjuvant CRT.

被引:0
|
作者
Bettoni, Fabiana [1 ]
Donnard, Elisa R. [1 ]
Correa, Bruna R. S. [1 ]
Asprino, Paula F. [1 ]
Koyama, Fernanda C. [2 ]
Felicio, Natalia M. [3 ]
Hessel, Bruna H. [4 ]
Galante, Pedro A. F. [1 ]
Camargo, Anamaria A. [2 ]
Habr-Gama, Angelita [4 ]
Perez, Rodrigo O. [5 ]
机构
[1] Hosp Sirio Libanes, Ctr Oncol Mol, Sao Paulo, Brazil
[2] Hosp Sirio Libanes, Ctr Oncol Mol, Inst Ludwig Pesquisa Canc, Sao Paulo, Brazil
[3] Hosp Alemao Oswaldo Cruz, Inst Angelita & Joaquim Gama, Sao Paulo, Brazil
[4] Inst Angelita & Joaquim Gama, Sao Paulo, Brazil
[5] Inst Ludwig Pesquisa Canc, Inst Angelita & Joaquim Gama, Sao Paulo, Brazil
关键词
D O I
10.1158/1535-7163.TARG-13-A133
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A133
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Cancer Stem Cells in Tumor Heterogeneity
    Pietras, Alexander
    INTRATUMOR DIVERSITY AND CLONAL EVOLUTION IN CANCER, 2011, 112 : 255 - 281
  • [42] Fragmented pattern of tumor regression and lateral intramural spread may influence margin appropriateness after TEM for rectal cancer following neoadjuvant CRT
    Perez, Rodrigo O.
    Habr-Gama, Angelita
    Smith, Fraser M.
    Kosinski, Lauren
    Sao Juliao, Guilherme P.
    Grzona, Esteban
    Rawet, Viviane
    Vianna, Maria Regina
    Proscurshim, Igor
    Lynn, Patricio Bernardo
    Gama-Rodrigues, Joaquim
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (08) : 853 - 858
  • [43] Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
    Repetto, Ombretta
    De Re, Valli
    De Paoli, Antonino
    Belluco, Claudio
    Alessandrini, Lara
    Canzonieri, Vincenzo
    Cannizzaro, Renato
    ONCOTARGET, 2017, 8 (17) : 28328 - 28341
  • [44] Positive ecological interaction between therapy-resistant and sensitive cells, mediated by stromal niche, slows the expansion of resistant subpopulations and promotes tumor heterogeneity
    Desai, Bina
    Robertson-Tessi, Mark
    Vander Velde, Robert
    Miti, Tatiana
    Yarlagadda, Sagnik
    Shah, Rishi
    Miroshnychenko, Daria
    Basanta, David
    Anderson, Alexander
    Marusyk, Andriy
    CANCER RESEARCH, 2024, 84 (03)
  • [45] Neoadjuvant treatment responses as a tumor necrosis grade for patients with rectal cancer
    Shim, B.
    Jung, J. H.
    Cho, H. M.
    Kim, H. J.
    Kim, S. W.
    Lee, J. H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S507 - S507
  • [46] Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?
    K. Horisberger
    R. D. Hofheinz
    P. Palma
    A. K. Volkert
    S. Rothenhoefer
    F. Wenz
    A. Hochhaus
    S. Post
    F. Willeke
    International Journal of Colorectal Disease, 2008, 23 : 257 - 264
  • [47] Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging
    Perez, R. O.
    Habr-Gama, A.
    Juliao, G. P. Sao
    Lynn, P. B.
    Sabbagh, C.
    Proscurshim, I.
    Campos, F. G.
    Gama-Rodrigues, J.
    Nahas, S. C.
    Buchpiguel, C. A.
    TECHNIQUES IN COLOPROCTOLOGY, 2014, 18 (08) : 699 - 708
  • [48] Are there any "High Risk" features in stage II rectal cancer after neoadjuvant CRT and radical surgery?
    Perez, Rodrigo O.
    Proscurshim, Igor
    Julio, Guilherme Sao
    Habr-Gama, Angelita
    Gama-Rodrigues, Joaquim
    Imperiale, Antonio R.
    Campos, Fabio
    Kiss, Desiderio
    Cecconello, Ivan
    GASTROENTEROLOGY, 2008, 134 (04) : A882 - A882
  • [49] Obstructing rectal cancer: time to tumor resection with and without neoadjuvant therapy
    Kim-Fuchs, C.
    Bruegger, L.
    Beldi, G.
    Vorburger, S.
    Candinas, D.
    SWISS MEDICAL WEEKLY, 2009, 139 (35-36) : 24S - 24S
  • [50] Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer
    Caricato, M.
    Ausania, F.
    De Dominicis, E.
    Vincenzi, B.
    Rabitti, C.
    Tonini, G.
    Cellini, F.
    Coppola, R.
    EJSO, 2007, 33 (06): : 724 - 728